DETTE Changement Date
AbbVie USD 70.82B 2.04B 2026-06
Agios Pharmaceuticals USD 31.17M 4.57M 2026-06
ALKERMES USD 1.57B 10.58M 2026-09
Alnylam Pharmaceuticals USD 2.48B 1.21B 2026-09
Amgen USD 57.3B 19M 2026-06
Biogen USD 7.69B 398.3M 2026-09
BioMarin Pharmaceutical USD 4.19B 11.99M 2026-09
Bristol-Myers Squibb USD 42.88B 2.18B 2026-09
Coherus Biosciences USD 294.92M 1.25M 2025-03
Eli Lilly USD 54.91B 11.54B 2026-06
Gilead Sciences USD 26.25B 4.07B 2026-06
GlaxoSmithKline GBP 18.24B 818M 2026-06
Glaxosmithkline GBP 23.7B 4.65B 2026-09
Incyte USD 38.27M 1.16M 2026-06
J&J USD 49.04B 5.95B 2026-06
Merck USD 53.91B 4.79B 2026-06
Moderna USD 1.29B 11M 2026-06
Neurocrine Biosciences USD 392.3M 9.5M 2026-09
Novartis USD 49.01B 2.02B 2026-06
Pfizer USD 62.67B 523M 2026-09
PTC Therapeutics USD 2.84B 2.15B 2026-09
Puma Biotechnology USD 89.06M 55.07M 2024-06
Regeneron Pharmaceuticals USD 2.71B 400K 2026-06
Sangamo BioSciences USD 0 0 2022-06
Sanofi EUR 23.58B 3.56B 2026-06
Sarepta Therapeutics USD 857.36M 188.48M 2026-09
United Therapeutics USD 200M 100M 2025-03
Vertex Pharmaceuticals USD 6.48B 4.5B 2026-09